vs

Side-by-side financial comparison of Colgate-Palmolive (CL) and PulteGroup (PHM). Click either name above to swap in a different company.

Colgate-Palmolive is the larger business by last-quarter revenue ($5.3B vs $3.4B, roughly 1.6× PulteGroup). Colgate-Palmolive runs the higher net margin — 12.1% vs 10.2%, a 2.0% gap on every dollar of revenue. On growth, Colgate-Palmolive posted the faster year-over-year revenue change (8.4% vs -12.4%). Over the past eight quarters, Colgate-Palmolive's revenue compounded faster (2.6% CAGR vs -13.9%).

The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.

PulteGroup, Inc. is an American residential home-construction company based in Atlanta, Georgia, United States. As of 2023, the company is the third-largest home-construction company in the United States based on the number of homes closed. In total, the company has built over 775,000 homes.

CL vs PHM — Head-to-Head

Bigger by revenue
CL
CL
1.6× larger
CL
$5.3B
$3.4B
PHM
Growing faster (revenue YoY)
CL
CL
+20.8% gap
CL
8.4%
-12.4%
PHM
Higher net margin
CL
CL
2.0% more per $
CL
12.1%
10.2%
PHM
Faster 2-yr revenue CAGR
CL
CL
Annualised
CL
2.6%
-13.9%
PHM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CL
CL
PHM
PHM
Revenue
$5.3B
$3.4B
Net Profit
$646.0M
$347.0M
Gross Margin
60.6%
Operating Margin
18.1%
Net Margin
12.1%
10.2%
Revenue YoY
8.4%
-12.4%
Net Profit YoY
-6.4%
EPS (diluted)
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CL
CL
PHM
PHM
Q1 26
$5.3B
$3.4B
Q4 25
$5.2B
$4.6B
Q3 25
$5.1B
$4.4B
Q2 25
$5.1B
$4.4B
Q1 25
$4.9B
$3.9B
Q4 24
$4.9B
$4.9B
Q3 24
$5.0B
$4.5B
Q2 24
$5.1B
$4.6B
Net Profit
CL
CL
PHM
PHM
Q1 26
$646.0M
$347.0M
Q4 25
$-36.0M
$501.6M
Q3 25
$735.0M
$585.8M
Q2 25
$743.0M
$608.5M
Q1 25
$690.0M
$522.8M
Q4 24
$738.0M
$913.2M
Q3 24
$737.0M
$697.9M
Q2 24
$731.0M
$809.1M
Gross Margin
CL
CL
PHM
PHM
Q1 26
60.6%
Q4 25
60.2%
Q3 25
59.4%
27.8%
Q2 25
60.1%
28.6%
Q1 25
60.8%
28.8%
Q4 24
60.3%
Q3 24
61.1%
30.4%
Q2 24
60.6%
31.4%
Operating Margin
CL
CL
PHM
PHM
Q1 26
18.1%
Q4 25
1.7%
Q3 25
20.6%
Q2 25
21.1%
Q1 25
21.9%
Q4 24
21.5%
Q3 24
21.2%
Q2 24
21.6%
Net Margin
CL
CL
PHM
PHM
Q1 26
12.1%
10.2%
Q4 25
-0.7%
10.9%
Q3 25
14.3%
13.3%
Q2 25
14.5%
13.8%
Q1 25
14.1%
13.4%
Q4 24
14.9%
18.6%
Q3 24
14.6%
15.6%
Q2 24
14.5%
17.6%
EPS (diluted)
CL
CL
PHM
PHM
Q1 26
$0.80
Q4 25
$-0.04
$2.56
Q3 25
$0.91
$2.96
Q2 25
$0.91
$3.03
Q1 25
$0.85
$2.57
Q4 24
$0.89
$4.41
Q3 24
$0.90
$3.35
Q2 24
$0.89
$3.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CL
CL
PHM
PHM
Cash + ST InvestmentsLiquidity on hand
$1.3B
$1.8B
Total DebtLower is stronger
Stockholders' EquityBook value
$13.0B
Total Assets
$16.6B
$5.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CL
CL
PHM
PHM
Q1 26
$1.3B
$1.8B
Q4 25
$1.4B
$2.0B
Q3 25
$1.3B
$1.5B
Q2 25
$1.2B
$1.2B
Q1 25
$1.1B
$1.2B
Q4 24
$1.3B
$1.6B
Q3 24
$1.2B
$1.4B
Q2 24
$1.1B
$1.4B
Total Debt
CL
CL
PHM
PHM
Q1 26
Q4 25
$7.8B
$43.9M
Q3 25
Q2 25
Q1 25
Q4 24
$7.0B
$31.1M
Q3 24
Q2 24
Stockholders' Equity
CL
CL
PHM
PHM
Q1 26
$13.0B
Q4 25
$54.0M
$13.0B
Q3 25
$856.0M
$12.8B
Q2 25
$702.0M
$12.6B
Q1 25
$363.0M
$12.3B
Q4 24
$212.0M
$12.1B
Q3 24
$435.0M
$11.6B
Q2 24
$123.0M
$11.2B
Total Assets
CL
CL
PHM
PHM
Q1 26
$16.6B
$5.2B
Q4 25
$16.3B
$18.0B
Q3 25
$17.5B
$17.9B
Q2 25
$17.5B
$17.6B
Q1 25
$16.6B
$17.3B
Q4 24
$16.0B
$17.4B
Q3 24
$16.8B
$17.0B
Q2 24
$16.5B
$16.5B
Debt / Equity
CL
CL
PHM
PHM
Q1 26
Q4 25
145.17×
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
33.04×
0.00×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CL
CL
PHM
PHM
Operating Cash FlowLast quarter
$159.8M
Free Cash FlowOCF − Capex
$609.0M
FCF MarginFCF / Revenue
11.4%
Capex IntensityCapex / Revenue
2.6%
0.7%
Cash ConversionOCF / Net Profit
0.46×
TTM Free Cash FlowTrailing 4 quarters
$3.8B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CL
CL
PHM
PHM
Q1 26
$159.8M
Q4 25
$1.5B
$771.1M
Q3 25
$1.3B
$678.4M
Q2 25
$884.0M
$287.5M
Q1 25
$600.0M
$134.2M
Q4 24
$1.3B
$567.6M
Q3 24
$1.2B
$455.9M
Q2 24
$990.0M
$417.5M
Free Cash Flow
CL
CL
PHM
PHM
Q1 26
$609.0M
Q4 25
$1.3B
$739.8M
Q3 25
$1.1B
$651.1M
Q2 25
$776.0M
$253.0M
Q1 25
$476.0M
$104.6M
Q4 24
$1.1B
$543.1M
Q3 24
$1.0B
$417.2M
Q2 24
$873.0M
$386.2M
FCF Margin
CL
CL
PHM
PHM
Q1 26
11.4%
Q4 25
24.4%
16.0%
Q3 25
21.6%
14.8%
Q2 25
15.2%
5.7%
Q1 25
9.7%
2.7%
Q4 24
21.9%
11.0%
Q3 24
20.5%
9.3%
Q2 24
17.3%
8.4%
Capex Intensity
CL
CL
PHM
PHM
Q1 26
2.6%
0.7%
Q4 25
3.4%
0.7%
Q3 25
3.0%
0.6%
Q2 25
2.1%
0.8%
Q1 25
2.5%
0.8%
Q4 24
3.7%
0.5%
Q3 24
2.7%
0.9%
Q2 24
2.3%
0.7%
Cash Conversion
CL
CL
PHM
PHM
Q1 26
0.46×
Q4 25
1.54×
Q3 25
1.72×
1.16×
Q2 25
1.19×
0.47×
Q1 25
0.87×
0.26×
Q4 24
1.72×
0.62×
Q3 24
1.58×
0.65×
Q2 24
1.35×
0.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CL
CL

Latin America$1.3B25%
Pet Nutrition$1.2B22%
Europe, Middle East & Africa (1)$1.1B21%
North America (1)$888.0M17%
Asia Pacific (1)$804.0M15%

PHM
PHM

Home sale revenues$3.3B97%
Financial Services$71.7M2%
Land sale and other revenues$29.3M1%

Related Comparisons